ANIP 8-K: SEC filing
ANI Pharmaceuticals
Filed with the SEC on · accession 0001104659-26-123446
ANIP filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -2.8% by the first close after the filing.
Summary of the filing
ANI Pharmaceuticals filed a routine Form 8-K cover page with no substantive event disclosed in the provided text.
Key details
How ANIP stock reacted
Close before
$71.65
Nov 4, 2026
First close after
-2.83%
$69.62
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ANIP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ANIP?
Click hereFrequently asked questions
What did ANIP file with the SEC on Nov 5, 2026?
ANIP filed a 8-K (SEC filing). ANI Pharmaceuticals filed a routine Form 8-K cover page with no substantive event disclosed in the provided text.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did ANIP stock react to this filing?
ANIP closed at $71.65 before the filing and $69.62 on Nov 5, 2026 (-2.83%).
Other ANIP SEC filings
Get alerts when ANIP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days